InsiderTrades.com logo
Tien-Li Lee net worth and biography
  • LinkedIn
  • Phone
  • Email
  • Website

Tien-Li Lee Biography and Net Worth

CEO of Aardvark Therapeutics

Dr. Lee has 20 years of experience as a biotechnology innovator and executive who has been integrally involved with the founding or advancement of several biopharmaceutical companies.

Since 2017, Dr Lee has been the founder/CEO of Aardvark Therapeutics, Inc. Prior to this, Dr. Lee joined Nantkwest in 2014 and served as its Chief Strategy Officer until March, 2017. His experience includes therapeutics for immunology, cardiovascular, oncology, neurology, and infectious disease indications. Dr. Lee is also an inventor or co-inventor of multiple biomedical and biotechnology innovations, licensed or assigned to several companies for development including Nantkwest, Simcere Pharmaceutical Group, Cellics Therapeutics, and Aardvark Therapeutics.

Dr. Lee earned his M.D. degree from UC San Diego and his B.A. degree from UC Berkeley in Molecular Biology where he was also a Regents and Alumni Scholar. Dr. Lee received post-graduate training in Internal Medicine through UC Los Angeles and Physical Medicine and Rehabilitation at UC Irvine.

What is Tien-Li Lee's net worth?

The estimated net worth of Tien-Li Lee is at least $19.14 million as of September 15th, 2025. Dr. Lee owns 1,543,384 shares of Aardvark Therapeutics stock worth more than $19,137,962 as of December 5th. This net worth estimate does not reflect any other investments that Dr. Lee may own. Learn More about Tien-Li Lee's net worth.

How do I contact Tien-Li Lee?

The corporate mailing address for Dr. Lee and other Aardvark Therapeutics executives is 4370 LA JOLLA VILLAGE DRIVE, SUITE 1050, SAN DIEGO, CA, 92122. Aardvark Therapeutics can also be reached via phone at (858) 225-7696 and via email at [email protected]. Learn More on Tien-Li Lee's contact information.

Has Tien-Li Lee been buying or selling shares of Aardvark Therapeutics?

Tien-Li Lee has not been actively trading shares of Aardvark Therapeutics during the last quarter. Most recently, on Monday, September 15th, Tien-Li Lee bought 10,000 shares of Aardvark Therapeutics stock. The stock was acquired at an average cost of $9.66 per share, with a total value of $96,600.00. Following the completion of the transaction, the chief executive officer now directly owns 1,543,384 shares of the company's stock, valued at $14,909,089.44. Learn More on Tien-Li Lee's trading history.

Who are Aardvark Therapeutics' active insiders?

Aardvark Therapeutics' insider roster includes Tien-Li Lee (CEO), and Nelson Sun (CFO). Learn More on Aardvark Therapeutics' active insiders.

Are insiders buying or selling shares of Aardvark Therapeutics?

In the last year, Aardvark Therapeutics insiders bought shares 7 times. They purchased a total of 62,542 shares worth more than $730,302.00. The most recent insider tranaction occured on September, 15th when CEO Tien-Li Lee bought 10,000 shares worth more than $96,600.00. Learn More about insider trades at Aardvark Therapeutics.

Information on this page was last updated on 9/15/2025.

Tien-Li Lee Insider Trading History at Aardvark Therapeutics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/15/2025Buy10,000$9.66$96,600.001,543,384View SEC Filing Icon  
9/12/2025Buy5,000$8.50$42,500.001,533,384View SEC Filing Icon  
9/11/2025Buy6,000$7.82$46,920.001,528,384View SEC Filing Icon  
9/10/2025Buy9,000$7.91$71,190.001,522,384View SEC Filing Icon  
2/14/2025Buy16,542$16.00$264,672.001,496,175View SEC Filing Icon  
See Full Table

Tien-Li Lee Buying and Selling Activity at Aardvark Therapeutics

This chart shows Tien-Li Lee's buying and selling at Aardvark Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Aardvark Therapeutics Company Overview

Aardvark Therapeutics logo
Aardvark Therapeutics, Inc. operates as a biotechnology company. It engages in the development of a novel small molecule therapeutics for obesity and metabolic diseases. The company was founded by Tien Lee in 2017 and is headquartered in San Diego, CA.
Read More

Today's Range

Now: $12.40
Low: $11.90
High: $12.83

50 Day Range

MA: $11.96
Low: $9.26
High: $17.41

2 Week Range

Now: $12.40
Low: $4.88
High: $19.58

Volume

241,894 shs

Average Volume

163,275 shs

Market Capitalization

$269.95 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A